Mersana Therapeutics, Inc.: capex
| Value | {"amount": 619000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2015-01-01 – 2015-12-31 |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/543f136d-a88e-4e0a-9ba1-a8c5e6717666
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-18-002479Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/capex/2015-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/543f136d-a88e-4e0a-9ba1-a8c5e6717666
History
- no predecessors — first report